Neurosurgery

Research: Surgeons, Hospitals Involved in Exceptional Research Have Lower Patient Mortality Rates, Fewer Complications

Retrieved on: 
Wednesday, April 3, 2024
Software, Research, Oncology, Technology, Hospitals, Health Technology, Science, Surgery, Cardiology, Neurology, Practice Management, Health, JAMA, Evidence-based medicine, Surgeon, Urology, Environment, Physician, Impact factor, Hospital, Mortality, Patient, General surgery, Neurosurgery, Ear, Woman, Otorhinolaryngology, Male, Publication, Novant Health, Harvard Business Review, Nose, Surgical oncology, Medicare, PubMed, Elective surgery, Gastroenterology

Surgeons and hospitals who conduct the most leading-edge research achieve lower rates of patient mortality and complications than those who do not, according to findings released today by Avant-garde Health.

Key Points: 
  • Surgeons and hospitals who conduct the most leading-edge research achieve lower rates of patient mortality and complications than those who do not, according to findings released today by Avant-garde Health.
  • Patients under the care of top surgeon-researchers showed a 5% lower rate of post-discharge complications and a 5% lower rate of mortality, within 30 days post-discharge, according to the research.
  • All 4,500 physicians and 350 hospitals being honored are listed on the Research All-Stars site .
  • In addition, a significant portion of the top surgeon-researchers – 47.1% on average – served as the leading or senior authors of their research.

Global Skull Clamp Market Analysis Report 2023-2024 & 2029 | Now Available - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
Health, Surgery, Neurology, Medical Devices, MRI, Prevalence, OPT, Application, Incidence, COVID-19, Acquisition, DSM-IV codes, Safety, Neurosurgery, Ageing, Video game

The "Global Skull Clamp Market: Analysis By Product, By Application, By Material, By Accessories, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Skull Clamp Market: Analysis By Product, By Application, By Material, By Accessories, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The global skull clamp market value stood at US$2.21 billion in 2023 and is expected to reach US$3.79 billion by 2029.
  • The global skull clamp market has witnessed continuous growth attributed to several key factors.
  • The global skull clamp market is fragmented, with an increasing number of large and medium-sized players accounting for the majority of the market revenue, and the presence of a substantial number of regional market players with limited business offerings and customer base.

Dr. Mark Silver Offers Options to Avoid Back Surgery

Retrieved on: 
Friday, March 22, 2024
General Health, Health, Surgery, Neurology, Nervous system, Nerve, Pain, Patient, Neurosurgery, Brain, Spinal cord stimulator, Diabetic neuropathy, Back pain, Dentistry

Dr. Mark Silver , founder of the Silver Spine and Neurological Center , offers treatments that can help many patients avoid the need for surgery to address back pain.

Key Points: 
  • Dr. Mark Silver , founder of the Silver Spine and Neurological Center , offers treatments that can help many patients avoid the need for surgery to address back pain.
  • “Surgery can be an effective form of back pain management,” said Dr. Mark Silver.
  • “But there are many other treatments that can avoid the need for surgery and should be considered.”
    Dr. Mark Silver is an expert on Neuromodulation, techniques that act directly on the nervous system.
  • By changing the way a patient’s nerves carry information to and from the brain, pain can be decreased and mobility improved.

Dr. Mark Viktor Silver – Maintains Unique Double Board Certification

Retrieved on: 
Monday, March 11, 2024
Health, Surgery, Neurology, Practice Management, Physical Therapy, General Health, University, Certification, McGill University, ABNS, Arm, Specialization, Surgeon, Column (periodical), Medical college, Patient, Neurosurgery, Human, General surgery, Neck, Deformity, Scoliosis, Spine, Physician, Royal college, School

Dr. Mark Viktor Silver , founder of the Silver Spine and Neurological Center , has maintained the unique distinction of being board-certified in neurosurgery by both the American Board of Neurological Surgery (ABNS) and the Royal College of Physicians and Surgeons of Canada.

Key Points: 
  • Dr. Mark Viktor Silver , founder of the Silver Spine and Neurological Center , has maintained the unique distinction of being board-certified in neurosurgery by both the American Board of Neurological Surgery (ABNS) and the Royal College of Physicians and Surgeons of Canada.
  • With more than 20 years of practice, Dr. Silver specializes in minimally invasive and complex neurosurgical procedures aimed at alleviating neck, back, arm, and leg pain.
  • “While not required for a medical license, the rigorous board certification process shows a physician’s commitment to his patients and profession,” said Dr. Silver.
  • With 21 years of professional practice, Dr Silver has worked in large academic and private institutions and has served as Chief of Neurosurgery at various prestigious hospitals.

Medcura Closes $22.4 Million Financing to Accelerate Development of Surgical Hemostatic Gel and Surgical Hemostasis Portfolio

Retrieved on: 
Wednesday, April 3, 2024
Textile, Powder, Paralysis, Trauma, Neurosurgery, Surgeon, Publication, Bleeding, Safety, Innovation system, Convertible, FDA, Economics, Pharmaceutical industry

The Company intends to use the proceeds from this Offering to accelerate the development of its lead surgical product, LifeGel™ Absorbable Hemostatic Gel.

Key Points: 
  • The Company intends to use the proceeds from this Offering to accelerate the development of its lead surgical product, LifeGel™ Absorbable Hemostatic Gel.
  • Current hemostatic agents swell and can cause neurological issues, including paralysis, when used in confined spaces routinely addressed in spinal surgery.
  • Medcura's Chief Executive Officer Jim Buck stated, "We remain highly encouraged by the continued momentum and pace of successes around our Life™ platform of innovative surgical hemostatic agents.
  • Our new and existing investor partners understand, and are aligned with, the Company's strategy to seismically transform the $2.8 billion worldwide biosurgery market for hemostatic agents.

Rady Children's Appoints Praveen Raju, MD, PhD, as the Nathan Gordon Chair and Medical Director of Neuro-Oncology Program

Retrieved on: 
Tuesday, April 2, 2024
Research, Diagnosis, Boston Children's Hospital, Brain, Health, Growth, Neurology, MSTP, Memory, Genetics, SAN, Patient, UC, Cancer, Medulloblastoma, Child, University, Neurosurgery, Doctor of Philosophy, Neuro, MD, Molecular biology, NIH, Laboratory, Pediatric neurosurgery, Neoplasm, Infant, Nathan Gordon, Hospital, Spinal cord, Pediatrics, Neuro-Oncology (journal), Medical director, Genetic distance, Nursing

At Rady Children's, Dr. Raju has also been named the Nathan Gordon Chair in Neuro-Oncology, established in 2021 to honor the memory of Nathan Gordon, who was diagnosed with a rare tumor in his spinal cord when he was just 15 months old.

Key Points: 
  • At Rady Children's, Dr. Raju has also been named the Nathan Gordon Chair in Neuro-Oncology, established in 2021 to honor the memory of Nathan Gordon, who was diagnosed with a rare tumor in his spinal cord when he was just 15 months old.
  • As part of Rady Children's nationally recognized care team, Dr. Raju will spearhead the growth of the Neuro-Oncology Program and advance research efforts on pediatric brain and spinal tumors.
  • By incorporating subspecialty expertise, Dr. Raju aims to address different forms of pediatric brain and spinal tumors.
  • By incorporating subspecialty expertise into the Neuro-Oncology Program, Dr. Raju aims to address the different forms and distinct molecular subtypes of pediatric brain and spinal tumors.

NEOS Cranial LOOP™ Receives FDA Clearance for CustomizedBone™ Use

Retrieved on: 
Tuesday, April 2, 2024
Anatomical terms of location, Patient, FDA, Neurosurgery, MRI, OTC, Medical device

CANTON, Conn., April 2, 2024 /PRNewswire/ -- Kelyniam Global (OTC:KLYG) and Fin-ceramica, Faenza S.p.a., makers of custom cranial implants, announced today that the NEOS Surgery Cranial LOOP™ fixation system has received 510(k) clearance from the FDA for use with Finceramica's CustomizedBone™ hydroxyapatite cranial implant.

Key Points: 
  • CANTON, Conn., April 2, 2024 /PRNewswire/ -- Kelyniam Global (OTC:KLYG) and Fin-ceramica, Faenza S.p.a., makers of custom cranial implants, announced today that the NEOS Surgery Cranial LOOP™ fixation system has received 510(k) clearance from the FDA for use with Finceramica's CustomizedBone™ hydroxyapatite cranial implant.
  • The Cranial LOOP™ family of cranial fixation devices is a smart system made of PEEK-OPTIMA™, a biocompatible polymer, for securely fixing bone flaps after craniotomies.
  • With more than 10 years of market experience, Cranial LOOP™ is being used in public and private hospitals in 25 countries worldwide.
  • The NEOS Surgery Cranial LOOP™ system offers rapid implant fixation in under two minutes using just three devices.

Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside

Retrieved on: 
Monday, April 1, 2024
Brain, Plasma, Head, L1, Concussion, Serum, GFAP, Patient, Biomarker, Research, TBI, Triage, University, Neurosurgery, Doctor of Philosophy, Glial fibrillary acidic protein, Head Injuries, Pediatrics, Traumatic brain injury, Hospital, San Francisco General Hospital, Glasgow Coma Scale, FDA, Health, Food, Medical imaging

The whole blood test on a portable instrument helps clinicians evaluate patients 18 years of age and older who present with suspected mild traumatic brain injury or mTBI, commonly known as concussion.

Key Points: 
  • The whole blood test on a portable instrument helps clinicians evaluate patients 18 years of age and older who present with suspected mild traumatic brain injury or mTBI, commonly known as concussion.
  • Test results can help rule out the need for a CT scan of the head and assist in determining the best next steps for patient care.
  • The i-STAT TBI cartridge with the i-STAT Alinity System requires a small venous blood sample, which is applied to the test cartridge.
  • Now, we have a whole blood test that can help assess the brain right at the patient's bedside – expanding access to more health providers and therefore patients."

Insights into the Future of Neurology Devices: Exploring the Global Market Report by BCC Research

Retrieved on: 
Thursday, March 28, 2024
Epilepsy, Organization, MRI, Prevalence, Brain, Multiple sclerosis, Data analysis, Neuro, Alzheimer's disease, Nervous system, Patient, Radiosurgery, Research, Spinal cord stimulator, Electrode, Parkinson's disease, Low back pain, Investment, DSM-IV codes, Neurosurgery, Population growth, Ageing, Medical imaging

BOSTON, March 28, 2024 /PRNewswire/ -- According to the latest research study, the demand for Neurology Devices: Global Markets expected to grow from $23.7 billion in 2023 to $31.7 billion by the end of 2028 at a compound annual growth rate (CAGR) of  6.0% from 2023 through 2028.

Key Points: 
  • Neurology Devices: Global Markets is basically a detailed study or report about the worldwide market for medical tools used in treating neurological conditions.
  • The report looks at things like how much these devices are used, where they're used, and how the market for them is growing.
  • This report thoroughly examines the global market for neurology devices, categorizing it by product type and region.
  • Non-surgeons are increasingly performing spinal cord stimulation procedures instead of neurosurgeons due to the rising global burden of low back pain.

Mercy Expands Primary & Specialty Care Network with New Community Physician site in Ellicott City

Retrieved on: 
Tuesday, March 12, 2024
Community, Growth, Sister, Mercy Hospital, Cardiology, Physician, Patient, Foot, Elective surgery, Baltimore metropolitan area, The Sisters of Mercy, Maryland School, University, Left, Ankle, Neurosurgery, Suite, Oella, Maryland, Gynaecology, Sisters of Mercy, Spine, Pain, Multimedia, Catholic Church, Rheumatology, Sports medicine, Nursing

BALTIMORE, Md., March 12, 2024 /PRNewswire-PRWeb/ -- As part of Mercy Health Services' ongoing efforts to expand the reach of the 149-year Sisters of Mercy tradition of quality health care, Mercy has officially opened Mercy Personal Physicians at Ellicott City. Located at 3290 N. Ridge Road, Suite 220, 2nd floor, Mercy Personal Physicians at Ellicott City is a comprehensive, one-stop, medical facility featuring primary care, specialized physician care, and a variety of diagnostic and laboratory services.

Key Points: 
  • As part of Mercy Health Services' ongoing efforts to expand the reach of the 149-year Sisters of Mercy tradition of quality health care, Mercy has officially opened Mercy Personal Physicians at Ellicott City.
  • BALTIMORE, Md., March 12, 2024 /PRNewswire-PRWeb/ -- As part of Mercy Health Services' ongoing efforts to expand the reach of the 149-year Sisters of Mercy tradition of quality health care, Mercy has officially opened Mercy Personal Physicians at Ellicott City.
  • Located at 3290 N. Ridge Road, Suite 220, 2nd floor, Mercy Personal Physicians at Ellicott City is a comprehensive, one-stop, medical facility featuring primary care, specialized physician care, and a variety of diagnostic and laboratory services.
  • Editor's Note: Maryland Family Care is the medical group practice which employs primary care physicians in the Mercy Personal Physicians network.